返回
Hoth Therapeutics Inc（HOTH）價格
HOTH 股價走勢圖
HOTH 收益
Hoth Therapeutics Inc
$1.04
-3.7%
$-0.04
收盤價：Jan 16, 16:00:00 GMT-5
$1.04
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$1.08
開盤價
$1.06
當日範圍
$1.03 - $1.09
52週區間
$0.655 - $2.11
交易量
354.2K
平均成交量
331.8K
每股盈餘 (TTM)
-1.64
股息收益率
--
市值
$16.1M
什麼是 HOTH？
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2019-02-15. The firm is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The firm also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).